U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07265271) titled 'A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma' on Nov. 24.
Brief Summary: Hepatocellular carcinoma (HCC) is often diagnosed at an advanced stage, and early detection is critical for improving patient outcomes. Despite this, reliable non-invasive biomarkers for early-stage HCC are limited.
This study seeks to develop a cell-free tsRNA (cf-tsRNA)-based liquid biopsy assay for accurate detection of early-stage HCC.
Study Start Date: Jan. 15
Study Type: OBSERVATIONAL
Condition:
Hepatocellular Carcinoma (HCC)
Intervention:
DIAGNOSTIC_TEST: Small RNA sequence
Comprehensive small RNA sequencing of serum...